サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1386590

リアルタイムPCR・デジタルPCRの世界市場：動向、予測、競合分析（～2030年）

Real-Time PCR and Digital PCR Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

リアルタイムPCR・デジタルPCRの世界市場：動向、予測、競合分析（～2030年）
出版日: 2023年10月12日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

リアルタイムPCR・デジタルPCRの動向と予測

世界のリアルタイムPCR・デジタルPCRの市場規模は、2024～2030年にかけてCAGR 7.2%で成長し、2030年までに約128億米ドルに達すると予測されています。この市場の主な促進要因は、感染症の有病率の上昇、バイオマーカー探索におけるPCRの利用拡大、分子検査への嗜好の拡大です。世界のリアルタイムPCR・デジタルPCR市場の将来は、病院と診断センター、研究室・学術機関、製薬・バイオ技術、臨床研究機関、法医学研究所市場での機会で有望に見えます。

リアルタイムPCR・デジタルPCR市場の洞察

Lucintelの予測では、予測期間中、臨床が最も高い成長を遂げる見込みです。

北米は、慢性疾患の有病率の高さ、新規かつ最先端のゲノム解析製品の使用の増加、同地域における主要プレイヤーの存在により、最大の地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがあるか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度あるか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えるか？

目次

第1章 エグゼクティブサマリー

第2章 世界のリアルタイムPCR・デジタルPCR市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析：2018～2030年

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のリアルタイムPCR・デジタルPCR市場の動向（2018～2023年）と予測（2024～2030年）
  • 世界のリアルタイムPCR・デジタルPCR市場：製品タイプ別
    • 試薬・消耗品
    • 機器
    • ソフトウェア
  • 世界のリアルタイムPCR・デジタルPCR市場：技術別
    • 定量的PCR
    • デジタルPCR
  • 世界のリアルタイムPCR・デジタルPCR市場：用途別
    • 臨床
    • 研究
    • 法医学
    • その他
  • 世界のリアルタイムPCR・デジタルPCR市場：最終用途別
    • 病院・診断センター
    • 研究室・学術機関
    • 製薬・バイオ技術
    • 臨床調査機関
    • 法医学研究所
    • その他

第4章 市場動向と予測分析：地域別（2018～2030年）

  • 世界のリアルタイムPCR・デジタルPCR市場：地域別
  • 北米のリアルタイムPCR・デジタルPCR市場
  • 欧州のリアルタイムPCR・デジタルPCR市場
  • アジア太平洋のリアルタイムPCR・デジタルPCR市場
  • その他の地域のリアルタイムPCR・デジタルPCR市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品タイプ別の世界のリアルタイムPCR・デジタルPCR市場の成長機会
    • 技術別の世界のリアルタイムPCR・デジタルPCR市場の成長機会
    • 用途別の世界のリアルタイムPCR・デジタルPCR市場の成長機会
    • 最終用途別の世界のリアルタイムPCR・デジタルPCR市場の成長機会
    • 地域別の世界のリアルタイムPCR・デジタルPCR市場の成長機会
  • 世界のリアルタイムPCR・デジタルPCR市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のリアルタイムPCR・デジタルPCR市場の生産能力拡大
    • 世界のリアルタイムPCR・デジタルPCR市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • F. Hoffmann La Roche
  • Takara Bio
  • Becton and Dickinson
  • Agilent Technologies
  • Merck KGaA
  • Qiagen
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Danaher
  • Bio Rad Laboratories
目次

Real-Time PCR and Digital PCR Trends and Forecast

The future of the global real-time PCR and digital PCR market looks promising with opportunities in the hospital and diagnostic center, research laboratory and academic institute, pharmaceutical and biotechnology, clinical research organization, and forensic laboratory markets. The global real-time PCR and digital PCR market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are rising prevalence of infectious diseases, growing usage of PCR in biomarker discovery, and expanding preference for molecular testing.

A more than 150-page report is developed to help in your business decisions.

Real-Time PCR and Digital PCR by Segment

The study includes a forecast for the global real-time PCR and digital PCR by product type, technology, application, end use, and region.

Real-Time PCR and Digital PCR Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents and Consumables
  • Instruments
  • Software

Real-Time PCR and Digital PCR Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Quantitative PCR
  • Digital PCR

Real-Time PCR and Digital PCR Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Clinical
  • Research
  • Forensic
  • Others

Real-Time PCR and Digital PCR Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Diagnostic Centers
  • Research Laboratories and Academic Institutes
  • Pharmaceutical and Biotechnology
  • Clinical Research Organizations
  • Forensic Laboratories
  • Others

Real-Time PCR and Digital PCR Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Real-Time PCR and Digital PCR Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies real-time PCR and digital PCR companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the real-time PCR and digital PCR companies profiled in this report include-

  • F. Hoffmann La Roche
  • Takara Bio
  • Becton and Dickinson
  • Agilent Technologies
  • Merck KGaA
  • Qiagen
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Danaher
  • Bio Rad Laboratories

Real-Time PCR and Digital PCR Market Insights

Lucintel forecasts that clinical is expected to witness highest growth over the forecast period.

North America will remain the largest region due to high prevalence of chronic diseases, increasing use of novel and cutting-edge genomic analysis products, and presence of key players in the region.

Features of the Global Real-Time PCR and Digital PCR Market

Market Size Estimates: Real-time PCR and digital PCR market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Real-time PCR and digital PCR market size by various segments, such as by product type, technology, application, end use, and region in terms of ($B).

Regional Analysis: Real-time PCR and digital PCR market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the real-time PCR and digital PCR market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the real-time PCR and digital PCR market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the real-time PCR and digital PCR market size?

Answer: The global real-time PCR and digital PCR market is expected to reach an estimated $12.8 billion by 2030.

Q.2 What is the growth forecast for real-time PCR and digital PCR market?

Answer: The global real-time PCR and digital PCR market is expected to grow with a CAGR of 7.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the real-time PCR and digital PCR market?

Answer: The major drivers for this market are rising prevalence of infectious diseases, growing usage of PCR in biomarker discovery, and expanding preference for molecular testing.

Q4. What are the major segments for real-time PCR and digital PCR market?

Answer: The future of the real-time PCR and digital PCR market looks promising with opportunities in the hospital and diagnostic center, research laboratory and academic institute, pharmaceutical and biotechnology, clinical research organization, and forensic laboratory markets.

Q5. Who are the key real-time PCR and digital PCR market companies?

Answer: Some of the key real-time PCR and digital PCR companies are as follows:

  • F. Hoffmann La Roche
  • Takara Bio
  • Becton and Dickinson
  • Agilent Technologies
  • Merck KGaA
  • Qiagen
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Danaher
  • Bio Rad Laboratories

Q6. Which real-time PCR and digital PCR market segment will be the largest in future?

Answer: Lucintel forecasts that clinical is expected to witness highest growth over the forecast period.

Q7. In real-time PCR and digital PCR market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to high prevalence of chronic diseases, increasing use of novel and cutting-edge genomic analysis products, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the real-time PCR and digital PCR market by product type (reagents and consumables, instruments, and software), technology (quantitative PCR and digital PCR), application (clinical, research, forensic, and others), end use (hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology, clinical research organizations, forensic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Real-Time PCR and Digital PCR Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Real-Time PCR and Digital PCR Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Real-Time PCR and Digital PCR Market by Product Type
    • 3.3.1: Reagents and Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software
  • 3.4: Global Real-Time PCR and Digital PCR Market by Technology
    • 3.4.1: Quantitative PCR
    • 3.4.2: Digital PCR
  • 3.5: Global Real-Time PCR and Digital PCR Market by Application
    • 3.5.1: Clinical
    • 3.5.2: Research
    • 3.5.3: Forensic
    • 3.5.4: Others
  • 3.6: Global Real-Time PCR and Digital PCR Market by End Use
    • 3.6.1: Hospitals and Diagnostic Centers
    • 3.6.2: Research Laboratories and Academic Institutes
    • 3.6.3: Pharmaceutical and Biotechnology
    • 3.6.4: Clinical Research Organizations
    • 3.6.5: Forensic Laboratories
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Real-Time PCR and Digital PCR Market by Region
  • 4.2: North American Real-Time PCR and Digital PCR Market
    • 4.2.1: North American Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
    • 4.2.2: North American Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others
  • 4.3: European Real-Time PCR and Digital PCR Market
    • 4.3.1: European Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
    • 4.3.2: European Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others
  • 4.4: APAC Real-Time PCR and Digital PCR Market
    • 4.4.1: APAC Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
    • 4.4.2: APAC Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others
  • 4.5: ROW Real-Time PCR and Digital PCR Market
    • 4.5.1: ROW Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
    • 4.5.2: ROW Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Technology
    • 6.1.3: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Application
    • 6.1.4: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by End Use
    • 6.1.5: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Region
  • 6.2: Emerging Trends in the Global Real-Time PCR and Digital PCR Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Real-Time PCR and Digital PCR Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Real-Time PCR and Digital PCR Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann La Roche
  • 7.2: Takara Bio
  • 7.3: Becton and Dickinson
  • 7.4: Agilent Technologies
  • 7.5: Merck KGaA
  • 7.6: Qiagen
  • 7.7: Abbott Laboratories
  • 7.8: Thermo Fisher Scientific
  • 7.9: Danaher
  • 7.10: Bio Rad Laboratories